Suppr超能文献

脓毒性休克患者液体管理的新见解。

New Insights into the Fluid Management in Patients with Septic Shock.

机构信息

Fourth Department of Internal Medicine, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Second Department of Pediatrics, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.

出版信息

Medicina (Kaunas). 2023 May 29;59(6):1047. doi: 10.3390/medicina59061047.

Abstract

The importance of fluid resuscitation therapy during the early stages of sepsis management is a well-established principle. Current Surviving Sepsis Campaign (SSC) guidelines recommend the early administration of intravenous crystalloid fluids for sepsis-related hypotension or hyperlactatemia due to tissue hypoperfusion, within the first 3 h of resuscitation and suggest using balanced solutions (BSs) instead of normal saline (NS) for the management of patients with sepsis or septic shock. Studies comparing BS versus NS administration in septic patients have demonstrated that BSs are associated with better outcomes including decreased mortality. After initial resuscitation, fluid administration has to be judicious in order to avoid fluid overload, which has been associated with increased mortality, prolonged mechanical ventilation, and worsening of acute kidney injury. The "one size fits all" approach may be "convenient" but it should be avoided. Personalized fluid management, based on patient-specific hemodynamic indices, provides the foundations for better patient outcomes in the future. Although there is a consensus on the need for adequate fluid therapy in sepsis, the type, the amount of administered fluids, and the ideal fluid resuscitation strategy remain elusive. Well-designed large randomized controlled trials are certainly needed to compare fluid choices specifically in the septic patient, as there is currently limited evidence of low quality. This review aims to summarize the physiologic principles and current scientific evidence regarding fluid management in patients with sepsis, as well as to provide a comprehensive overview of the latest data on the optimal fluid administration strategy in sepsis.

摘要

在脓毒症管理的早期阶段,液体复苏治疗的重要性是一个既定的原则。目前的《拯救脓毒症运动(SSC)》指南建议,在复苏的最初 3 小时内,对与脓毒症相关的低血压或组织灌注不足引起的高乳酸血症,早期给予静脉晶体液,建议使用平衡溶液(BSs)代替生理盐水(NS)来管理脓毒症或脓毒性休克患者。比较 BS 与 NS 在脓毒症患者中的应用的研究表明,BSs 与更好的结果相关,包括降低死亡率。在初始复苏后,必须谨慎进行液体管理,以避免液体超负荷,这与死亡率增加、机械通气延长和急性肾损伤恶化有关。“一刀切”的方法可能是“方便”的,但应该避免。基于患者特定的血流动力学指标的个性化液体管理为未来更好的患者预后提供了基础。尽管人们一致认为脓毒症需要充分的液体治疗,但液体的类型、给予的液体量和理想的液体复苏策略仍然难以捉摸。当然,需要精心设计的大型随机对照试验来比较脓毒症患者的液体选择,因为目前低质量的证据有限。本综述旨在总结脓毒症患者液体管理的生理原则和当前的科学证据,并对脓毒症最佳液体给予策略的最新数据进行全面概述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a25a/10301281/3d8849b128b5/medicina-59-01047-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验